TAT-11: Investigation of Monocarbon Carboranes as Pendant Groups for Labeling Small Molecules with Astatine-211

Ottawa, ON, Canada (UroToday.com) Dr. Li motivated the search for new labeling compounds by noting that previous experiences with Biotin as a carrier were not very successful since it exited the body before saturating the tumor. As alternatives, Dr. Li described the development of two monocarbon carboranes. One of these, 1-(p-Bz)-closo-CB9H8-OH, when labeled with At211 provides high radiochemical yields in vivo stability is being evaluated.

Presented by: Yawen Li, PhD, University of Washington-Seattle, Seattle, Washingto, United States

Written by: William Carithers, Lawrence Berkeley National Laboratory at the 11th International Symposium on Targeted Alpha Therapy (TAT-10)  April 1 - April 4, 2019 - Ottawa, ON, Canada

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.